Compare C3.ai Inc (AI) vs GSK plc (GSK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
C3.ai Inc vs GSK plc — how do they compare? C3.ai Inc trades at $8.86 (market cap $1.39B), while GSK plc trades at $52.63 (market cap $105.91B). The key difference: GSK plc is far larger — about 76.2× C3.ai Inc's market cap, and GSK plc pays a 3.38% dividend while C3.ai Inc pays none. Which is the better fit depends on your goals.
| AI | GSK | |
|---|---|---|
Market Cap | $1.39B | $105.91B |
Sector | Technology | Health |
52-Week High | $29.16 | $61.18 |
52-Week Low | $7.76 | $36.20 |
Enterprise Value | $818.29M | $126.53B |
Dividend Yield | — | 3.38% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About C3.ai Inc
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
